Arthneeti
FDC Ltd Q2 FY27 results are out (Jul–Sep 2026) →Revenue ₹572 Cr +20.9% YoYSee revenue, profit and what management said. You are viewing Q2 FY17.
F

FDC Ltd

Q2 FY17Pharmaceuticals & Biotechnology

FDC Q2 FY17 earnings call: Revenue & Margins

Q2 FY17 investor presentation: what the company reported on revenue, margins and capex.

Based on FDC Ltd's Q2 FY17 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹346
Market cap₹5.7K Cr
P/E18.6

The short version

Total Revenue for Q2 FY 2016: Approx.

From FDC Ltd's Q2 FY17 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Total Revenue for Q2 FY 2016: Approx. Rs. 265 Crores (Page 8)
  • Total Revenue for Q2 FY 2015: Approx. Rs. 292 Crores (Page 8)
  • Year-on-year revenue decline: Around (10%) to (6%) depending on the exact metric (Page 8)
  • FDC domestic sales for 1st Half Year 2016: Approx. Rs. 530 Crores, down from Rs. 564 Crores in 1st Half Year 2015 (Page 8)
  • Primary internal sales growth Apr-Sept 2016: 6.4% (Page 8)

2 more points from FDC Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what FDC Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

See what FDC Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Pharmaceuticals & Biotechnology

Ranked on what management guided this quarter

Guidance-ranked
1Ind-Swift Laboratories
Rev 1Mar 1
2KRM Ayurveda
Rev 1Mar 1
3
Rev 1Mar 2
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

Specifically:

Locked: what FDC Ltd said on fundraising

Also locked on this page: margins, capex

Free account, 30 seconds. No card needed.

Order Book & Pipeline

Specifically: - There is no reference to order book or pending orders in any of the pages. - Key financial data includes revenues, sales performance, growth rates, and assets and liabilities. - Market data such as brand rankings, therapy segment information, and sales growth is provided.

FDC Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹572 Cr, net profit ₹49 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What FDC's management said in earlier quarters

Earlier calls (6)

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

FDC Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were FDC Ltd Q2 FY17 results?

Total Revenue for Q2 FY 2016: Approx.

What is FDC Ltd share price analysis?

FDC Ltd currently shows a neutral. The stock trades at a P/E of 18.6 with a market cap of ₹5,739 Cr. Investors should review the full earnings analysis for detailed insights.

Keep FDC Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.